<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:department>School of Biosciences</gtr:department><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A5D82856-CA6F-41F3-A5D3-B875D4D92277"><gtr:id>A5D82856-CA6F-41F3-A5D3-B875D4D92277</gtr:id><gtr:firstName>Rosemary</gtr:firstName><gtr:otherNames>A</gtr:otherNames><gtr:surname>Fricker</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/EBF62057-C51F-47BB-9B80-D3AA4A7ACD29"><gtr:id>EBF62057-C51F-47BB-9B80-D3AA4A7ACD29</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>B.</gtr:otherNames><gtr:surname>Dunnett</gtr:surname><gtr:orcidId>0000-0003-1826-1578</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0E2D5D54-CB45-4381-862C-A68518D21BAE"><gtr:id>0E2D5D54-CB45-4381-862C-A68518D21BAE</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Edwards</gtr:surname><gtr:orcidId>0000-0003-2264-9823</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/35939D69-D0EC-46C5-BDEF-7631ECB64C8A"><gtr:id>35939D69-D0EC-46C5-BDEF-7631ECB64C8A</gtr:id><gtr:firstName>Angelo</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Amoroso</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0300261"><gtr:id>D4B9806A-B8DA-4D7E-A95E-968B3DBAE433</gtr:id><gtr:title>Novel Protocols for Magnetic Resonance Imaging of Stem Cell Transplants in the Brain</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300261</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>317437</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Max Planck Institute for Neurological Research</gtr:department><gtr:description>EU FP6 StemStroke</gtr:description><gtr:id>C96760AE-50B2-473F-9E8D-C1D1339C57E7</gtr:id><gtr:impact>Developing novel methods of imaging and behaviour for analysis of stem cell transplantation in experimental stroke</gtr:impact><gtr:partnerContribution>training in (i) MCAO technology and (ii) optimisation of MRI imaging protocols for experimental stroke</gtr:partnerContribution><gtr:piContribution>Developing novel methods of imaging and behaviour for analysis of stem cell transplantation in experimental stroke</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>results included in multiple public and academic lectures and seminars</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>DA3ED676-F113-4C01-A2E2-89B3C765BAA8</gtr:id><gtr:impact>results included in multiple public and academic lectures and seminars

various</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>10-15 presentations to HDA and PDS patient groups.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>B606EDCC-0441-4BDE-BB11-F76E9F0F936C</gtr:id><gtr:impact>I present regular medical and lay seminars around the country and internationally. I am afraid I am unable to list all the individual presentations.

various</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>10-15 presentations to HDA and PDS patient groups</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>9A2005BE-3D43-4471-9303-0423D7AED843</gtr:id><gtr:impact>10-15 presentations to HDA and PDS patient groups. I present regular medical and lay seminars around the country and internationally. I am afraid I am unable to list all the individual presentations.

academic, medical and patient contacts</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>results included in multiple public and academic lectures and seminars</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C2A7D5E8-B3ED-44B5-BF6D-BB20026C1F98</gtr:id><gtr:impact>results included in multiple public and academic lectures and seminars

various</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>10-15 presentations to HDA and PDS patient groups.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>33FDF369-D968-4873-A6FB-B20C6EEF8D24</gtr:id><gtr:impact>10-15 presentations to HDA and PDS patient groups. I present regular medical and lay seminars around the country and internationally. I am afraid I am unable to list all the individual presentations.

various</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>10-15 presentations to HDA and PDS patient groups.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>DDDCC5FB-06BA-4B3B-A936-1CE123993F47</gtr:id><gtr:impact>I present regular medical and lay seminars around the country and internationally. I am afraid I am unable to list all the individual presentations.

various</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>262342</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>STEMSTROKE Towards a stem cell therapy for stroke (2.5m euros across 6 participants)</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:id>DB80EB95-5B5F-48F4-93D4-E29DE3E1CC39</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>GTAC</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>C496B9D2-DE80-493D-A94C-C13E72B73306</gtr:id><gtr:impact>member of GTAC committee reviewing applications and developing policy on stem cell and gene therapy trials in the UK</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>GTAC</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>226DE131-B64B-4DF2-9B02-BCF6D1CEC6F4</gtr:id><gtr:impact>development of national ethical and regulatory guidelines</gtr:impact><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>17556DC1-EE13-4C69-B0AB-8A4A950EE996</gtr:id><gtr:impact>Targetted direction, policy and funding of UK stem cell research .</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC stem cell</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>837418BC-C26D-4833-B76F-E65FBD410F3C</gtr:id><gtr:impact>I participate in the MRC Stem Cell Bank User's group and participate regularly in MRC stem cell policy and funding strategy meetings at Head Office.</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>regular citations in clinical reviews and publications</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>9019722F-1DE3-4C23-9C56-6C90EF3E9982</gtr:id><gtr:impact>influence on development of NECTAR and ASNTR guidelines</gtr:impact><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Stem Cells</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>6D89B533-4921-4D8A-A007-F43463C3F113</gtr:id><gtr:impact>I participate in the MRC UK Stem Cell Bank users group and contribute regularly to the policy discussions at head office on stem cell strategy and funding.</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Validation of alternative protocols for consented collection of human fetal tissue</gtr:description><gtr:id>BA4D2056-FE96-45B5-962B-340B28891701</gtr:id><gtr:impact>Resolves the outstanding block on limited tissue availability to allow multiple international research and clinical trials to resume.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>mTOPs</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3DAD8503-05BE-4ED1-B99D-FE11EC56AB24"><gtr:id>3DAD8503-05BE-4ED1-B99D-FE11EC56AB24</gtr:id><gtr:title>A facile one-pot synthesis of a new cryptand via a Pd(II)-catalysed carbonylation reaction.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e15315db76742e316407bfef699d4994"><gtr:id>e15315db76742e316407bfef699d4994</gtr:id><gtr:otherNames>Knight JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A3EF3BF4-4D45-4EE2-8333-5ACFCC433CC8"><gtr:id>A3EF3BF4-4D45-4EE2-8333-5ACFCC433CC8</gtr:id><gtr:title>The synthesis and coordination chemistry of a tris-8-aminoquinoline tripodal ligand.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b85b48559ccc7c9aa233b2b5b2fcb6c8"><gtr:id>b85b48559ccc7c9aa233b2b5b2fcb6c8</gtr:id><gtr:otherNames>Amoroso AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A4900367-97F1-4270-BBB2-4E29F8CC9D31"><gtr:id>A4900367-97F1-4270-BBB2-4E29F8CC9D31</gtr:id><gtr:title>A novel bipyridine-based hexadentate tripodal framework with a strong preference for trigonal prismatic co-ordination geometries.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e15315db76742e316407bfef699d4994"><gtr:id>e15315db76742e316407bfef699d4994</gtr:id><gtr:otherNames>Knight JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300261</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>12A0B409-0C29-4056-9092-2D86E44017F3</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.4  Methodologies and measurements</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>